jueves, 1 de julio de 2021

FDA approves asparaginase erwinia chrysanthemi (recombinant) for leukemia and lymphoma | FDA

FDA approves asparaginase erwinia chrysanthemi (recombinant) for leukemia and lymphoma | FDA

No hay comentarios:

Publicar un comentario